Crossmark

Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development

Crossref DOI link: https://doi.org/10.1038/srep04703

Published Online: 2014-04-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moraes, Carolina B.

Giardini, Miriam A.

Kim, Hwayoung

Franco, Caio H.

Araujo-Junior, Adalberto M.

Schenkman, Sergio

Chatelain, Eric

Freitas-Junior, Lucio H.
License Information

Text and Data Mining valid from 2014-04-16

Version of Record valid from 2014-04-16
More Information

Article History

Received: 9 December 2013

Accepted: 24 March 2014

First Online: 16 April 2014

Competing interests

: The authors declare no competing financial interests.

Document is current

Any future updates will be listed below